 |
Scientific News Health care Therapy of a gene VACCINE AGAINST MAD COW DISEASE NOW POSSIBLE
VACCINE AGAINST MAD COW DISEASE
NOW POSSIBLE
|

|
|
An infectious prion with a targeted amino
acid sequence highlighted (N. Cashman, University of Toronto)
|
A new antibody capable of locking onto the prion
proteins that cause brain-wasting mad cow disease - and similar human ailments -
has been developed by researchers, allowing early diagnosis and maybe even a
vaccine.
The deformed 'prion' proteins which cause the diseases carry a distinct genetic
signature that antibodies - immune system proteins in the body - can be trained
to recognise, the international team of scientists report in the latest issue of
the journal Nature Medicine.
Led by Professor Neil Cashman of Canada's University
of Toronto, the team is already working on a vaccine using the new antibody.
"If we did get a vaccine, it would be wonderful to use in cattle and sheep,
and deer and elk, to prevent these diseases," Cashman said. "But for
humans that are developing symptoms, probably a vaccine would not be the way to
go. Probably passive infusion of prion-specific antibodies would be the way to
go."
The conventional way of 'training' the immune system to recognise an invader is
to grind the infectious agent up and inject this into the body, prompting the
production of antibodies that target the invading agent. But this method has
been tried on prions for 15 years without success.
"My group decided to examine it from the sub-molecular level - to determine
if antibodies would recognise and react to the amino acids exposed at the
surface of a prion," Cashman said. "It was a novel idea, and when we
found that our hypothesis actually worked, we were surprised and pleased."
Bovine spongiform encephalopathy (BSE), or mad cow disease, is back in the
headlines after a Canadian cow was found to be infected. Countries that import
beef from Canada, including Australia, have suspended imports while the case is
investigated.
BSE swept through British cattle in the 1980s, forcing the slaughter of millions
of beasts. Some people who ate contaminated beef during that time have since
developed a human form of the disease - variant Creutzfeldt-Jakob disease (vCJD).
According to the World Health Organisation, 139 people have been diagnosed with
vCJD; most have died.
Fatal diseases
Both BSE and vCJD are members of a family of diseases called transmissible
spongiform encephalopathies (TSEs). They are always fatal, and there is no cure
or treatment. They often take years to develop, destroying the brain by eating
holes in it.
In 1990s, scientists discovered that normal prion proteins, which have been
compromised and folded into rogue shapes, cause these diseases and can warp
healthy proteins simply by touching them.
Sheep get a TSE called scrapie; deer and elk develop chronic wasting disease;
and cats, mink, mice and other animals can be infected. Humans are susceptible
to several TSEs, including vCJD, kuru (found in populations where cannibalism is
practised), and the better-known Creutzfeldt-Jakob disease, which occurs for
unknown reasons in about one in a million people.
TSEs can only be definitively diagnosed after death, by looking at the damaged
brain. "For blood screening, and for the screening of herds, one would want
to have a non-invasive test," Cashman said. His team's antibody may provide
this - providing a boon to blood banks and cattle farmers around the world.
Mad cow experts in Britain have developed a tonsil test for vCJD. But it
requires a sample to be taken from a person's throat and, if the test is
positive, there is no treatment that can be offered.
Cashman said it is unclear if infusing antibodies into a vCJD patient would help.
The approach works short-term in other diseases, such as severe acute
respiratory syndrome (SARS) and hepatitis.
"There is no science yet for how long it [the infective prion] takes to go
away," he said. "These things we'd really have to find out from
scratch."
Cashman's team, which included researchers in Britain and the United States,
worked with two U.S. companies: IDEXX Laboratories Inc, which develops
veterinary treatments, and privately-held Caprion Pharmaceuticals Inc.
Source of the given news and the copyrights
belong to a ABC
Online News
Publishing date: June 10, 2003
Back
|  |